[Diabetic ketoacidosis in children and adolescents]

Naomi Weintrob1, Moshe Phillip

  • 1The Institute for Endocrinology and Diabetes, National Center for Childhood Diabetes, Schneider Children's Medical Center of Israel and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv. weintrob@netvision.net.il

Harefuah
|February 8, 2008
PubMed

Insights

Diabetic ketoacidosis (DKA) is a severe diabetes complication in children. This survey provides guidelines for DKA treatment and prevention, emphasizing early diagnosis and careful management to reduce mortality.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Diabetes Mellitus Research

Context:

  • Diabetic ketoacidosis (DKA) is a significant cause of hospitalization and mortality in children with type 1 diabetes.
  • Despite advances in understanding and management, DKA incidence remains high in Western countries.
  • Cerebral edema, a primary cause of DKA-related death, also persists at concerning rates.

Purpose:

  • To present current guidelines for the treatment of diabetic ketoacidosis (DKA) in pediatric patients.
  • To recommend effective preventive strategies for DKA in children with diabetes mellitus.
  • To consolidate consensus on DKA management protocols.

Summary:

  • DKA management involves slow rehydration with isoosmotic fluids, avoiding bicarbonate except in rare instances.
  • Continuous monitoring of glucose, sodium, potassium levels, and neurological status is crucial during DKA treatment.
  • Prevention strategies include early diabetes diagnosis and diligent management of intercurrent illnesses in known diabetic children.

Impact:

  • Aims to reduce DKA-related hospitalizations and mortality in pediatric populations.
  • Enhances clinical team's ability to manage DKA effectively and implement preventive measures.
  • Contributes to improved long-term outcomes for children with type 1 diabetes by addressing DKA risks.

Related Concept Videos

Diabetic Ketoacidosis l: Introduction01:25

Diabetic Ketoacidosis l: Introduction

DefinitionDiabetic ketoacidosis (DKA) is an acute, life-threatening complication of diabetes mellitus, characterized by a triad of hyperglycemia (blood glucose >250 mg/dL), ketonemia or ketonuria, and metabolic acidosis (arterial pH <7.30 and serum bicarbonate <18 mEq/L). It results from insulin deficiency combined with elevated levels of counterregulatory hormones—glucagon, catecholamines, cortisol, and growth hormone—leading to increased lipolysis, hepatic ketone production, and...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...